Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT06349902
Eligibility Criteria:
Inclusion Criteria:
For the retrospective chart review element of the study, inclusion criteria includes anyone who had a telemedicine visit at the community based substance use telemedicine program between January 1st 2023 and December 31st 2024.
For the prospective cohort element of the study, the inclusion criteria are listed below:
Aged ≥18. Ability and willingness of the participant to provide informed consent. Having a positive HCV RNA laboratory result and lacking a sufficient previous course of DAA treatment.
Exclusion Criteria:
For the retrospective chart review element of the study, exclusion criteria is: a consent directive to restrict access to their OLIS record.
For the prospective cohort study, exclusion criteria is an inability or unwillingness of the participant to provide informed consent.
\-
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06349902
Study Brief:
Protocol Section:
NCT06349902